Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
Isaac G. Onyango
Neural Regeneration Research (2018) Vol. 13, Iss. 1, pp. 19-19
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies
Tao Song, Xiaopeng Song, Chenyawen Zhu, et al.
Ageing Research Reviews (2021) Vol. 72, pp. 101503-101503
Open Access | Times Cited: 203
Mitochondrial Transfer as a Novel Therapeutic Approach in Disease Diagnosis and Treatment
Vicente Javier Clemente‐Suárez, Alexandra Martín-Rodríguez, Rodrigo Yáñez‐Sepúlveda, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8848-8848
Open Access | Times Cited: 55
Mitochondrial dysfunction and therapeutic perspectives in osteoporosis
Jialing Liu, Zhonghua Gao, Xiangjie Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 20
Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases
Pengwei Li, Mingxian Chang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7688-7688
Open Access | Times Cited: 90
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
K. Y. Wong, Jaydeep Roy, Man Lung Fung, et al.
Aging and Disease (2020) Vol. 11, Iss. 5, pp. 1291-1291
Open Access | Times Cited: 88
Ramadan diurnal intermittent fasting modulates SOD2, TFAM, Nrf2, and sirtuins (SIRT1, SIRT3) gene expressions in subjects with overweight and obesity
Mohamed Madkour, Ahmed El-Serafi, Haitham Jahrami, et al.
Diabetes Research and Clinical Practice (2019) Vol. 155, pp. 107801-107801
Closed Access | Times Cited: 87
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 58
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 957-969
Open Access | Times Cited: 62
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease
Seungmin Yoo, Jisu Park, Seohyun Kim, et al.
BMB Reports (2020) Vol. 53, Iss. 1, pp. 35-46
Open Access | Times Cited: 59
Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats
Debapriya Garabadu, Jaya Verma
Neurochemistry International (2019) Vol. 128, pp. 39-49
Closed Access | Times Cited: 57
Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases
Feres José Mocayar Marón, Alejandra B. Camargo, Walter Manucha
Life Sciences (2020) Vol. 249, pp. 117513-117513
Closed Access | Times Cited: 52
The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease
Tan Sook Ling, Shanthini Chandrasegaran, Zhi Xuan Low, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 44
Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
Gurjit Kaur Bhatti, Anshika Gupta, Paras Pahwa, et al.
Biomedical Journal (2022) Vol. 45, Iss. 5, pp. 733-748
Open Access | Times Cited: 31
Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
Rui Wang, Yi Zhu, Lanfang Qin, et al.
Dementia and Geriatric Cognitive Disorders (2023) Vol. 52, Iss. 2, pp. 47-73
Closed Access | Times Cited: 21
Allicin: A review of its important pharmacological activities
Vivek D. Savairam, Neha Patil, Shrikant R. Borate, et al.
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 8, pp. 100283-100283
Open Access | Times Cited: 20
Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
Rui Li, Yuan Qu, Yi Liu, et al.
Neural Regeneration Research (2019) Vol. 14, Iss. 6, pp. 931-931
Open Access | Times Cited: 44
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Anna Atlante, Giuseppina Amadoro, Valentina Latina, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6742-6742
Open Access | Times Cited: 24
Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target
Ya-Na Yang, Mao-Qing Zhang, Feng-Lin Yu, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115717-115717
Closed Access | Times Cited: 16
Passive Aβ Immunotherapy: Current Achievements and Future Perspectives
Stephan Schilling, Jens‐Ulrich Rahfeld, Inge Lues, et al.
Molecules (2018) Vol. 23, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 45
The TRPM2 channel nexus from oxidative damage to Alzheimer’s pathologies: An emerging novel intervention target for age-related dementia
Lin‐Hua Jiang, Xin Li, Sharifah Alawieyah Syed Mortadza, et al.
Ageing Research Reviews (2018) Vol. 47, pp. 67-79
Open Access | Times Cited: 45
HIV in the cART era and the mitochondrial: immune interface in the CNS
Jerel Adam Fields, Ronald J. Ellis
International review of neurobiology (2019), pp. 29-65
Open Access | Times Cited: 42
Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation
Forouzan Khodaei, Marzieh Rashedinia, Reza Heidari, et al.
Life Sciences (2019) Vol. 237, pp. 116954-116954
Closed Access | Times Cited: 40
Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance
Cristina Carvalho, Susana Cardoso
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 8, pp. 631-649
Closed Access | Times Cited: 37
Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy
Kaiming Liu, Zhijian Zhou, Mengxiong Pan, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 7, pp. 733-742
Open Access | Times Cited: 31
Naringin Exhibits Mas Receptor–Mediated Neuroprotection Against Amyloid Beta–Induced Cognitive Deficits and Mitochondrial Toxicity in Rat Brain
Vibhav Varshney, Debapriya Garabadu
Neurotoxicity Research (2021) Vol. 39, Iss. 4, pp. 1023-1043
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top